Timing and treatment strategies according to SCAI classification in cardiogenic shock

Standard

Timing and treatment strategies according to SCAI classification in cardiogenic shock. / Tarantini, Giuseppe; Masiero, Giulia; Thiele, Holger; Iannaccone, Mario; Schrage, Benedikt; Hassager, Christian; Woitek, Felix; Chieffo, Alaide; Møller, Jacob Eifer.

In: EUR HEART J SUPPL, Vol. 25, No. Suppl I, 12.2023, p. I19-I23.

Research output: SCORING: Contribution to journalShort publicationResearchpeer-review

Harvard

Tarantini, G, Masiero, G, Thiele, H, Iannaccone, M, Schrage, B, Hassager, C, Woitek, F, Chieffo, A & Møller, JE 2023, 'Timing and treatment strategies according to SCAI classification in cardiogenic shock', EUR HEART J SUPPL, vol. 25, no. Suppl I, pp. I19-I23. https://doi.org/10.1093/eurheartjsupp/suad129

APA

Tarantini, G., Masiero, G., Thiele, H., Iannaccone, M., Schrage, B., Hassager, C., Woitek, F., Chieffo, A., & Møller, J. E. (2023). Timing and treatment strategies according to SCAI classification in cardiogenic shock. EUR HEART J SUPPL, 25(Suppl I), I19-I23. https://doi.org/10.1093/eurheartjsupp/suad129

Vancouver

Bibtex

@article{43404519907146e9b3e6735d19fc481e,
title = "Timing and treatment strategies according to SCAI classification in cardiogenic shock",
abstract = "In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.",
author = "Giuseppe Tarantini and Giulia Masiero and Holger Thiele and Mario Iannaccone and Benedikt Schrage and Christian Hassager and Felix Woitek and Alaide Chieffo and M{\o}ller, {Jacob Eifer}",
note = "{\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.",
year = "2023",
month = dec,
doi = "10.1093/eurheartjsupp/suad129",
language = "English",
volume = "25",
pages = "I19--I23",
journal = "EUR HEART J SUPPL",
issn = "1520-765X",
publisher = "Oxford University Press",
number = "Suppl I",

}

RIS

TY - JOUR

T1 - Timing and treatment strategies according to SCAI classification in cardiogenic shock

AU - Tarantini, Giuseppe

AU - Masiero, Giulia

AU - Thiele, Holger

AU - Iannaccone, Mario

AU - Schrage, Benedikt

AU - Hassager, Christian

AU - Woitek, Felix

AU - Chieffo, Alaide

AU - Møller, Jacob Eifer

N1 - © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2023/12

Y1 - 2023/12

N2 - In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.

AB - In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.

U2 - 10.1093/eurheartjsupp/suad129

DO - 10.1093/eurheartjsupp/suad129

M3 - Short publication

C2 - 38093764

VL - 25

SP - I19-I23

JO - EUR HEART J SUPPL

JF - EUR HEART J SUPPL

SN - 1520-765X

IS - Suppl I

ER -